Anifrolumab-containing medicinal products
Original notice title
Czechia – Immunosuppressive agents – Léčivé přípravky s obsahem anifrolumabu
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
67 / 100
Risk factors
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Fakultní nemocnice Hradec Králové
- Country
- Czech Republic
- CPV
- 33652300 - Immunosuppressive agents
- Deadline
- Nov 10, 2026
- Estimated value
- CZK 9.1M (approx. EUR 372k)
Overview
Moderate opportunityKey Facts
- CZK 9.1M estimated value
- Supplies contract
- 1 lot
- Duration 4 YEAR
- Ongoing supply of medicinal products containing anifrolumab.
- Deliveries are to be made according to the contracting authority's current needs.
Show full summary
Open procedure for four years of ongoing supplies of medicinal products containing anifrolumab, classified as immunosuppressive agents. The estimated value is CZK 9,064,670 and performance is in Czechia. Electronic submission is required and the stated language is Czech. Procurement documents are referenced but no extracted document text was provided, so key commercial, technical, eligibility, and submission details remain unverified.
Risks
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The procedure is an open procedure.
Administrative
- Electronic submission is required.
- The stated language is Czech.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hradec Králové - Nový Hradec Králové, CZE
Website
Buyer profile
Identifier
00179906
Activity
Health
Lots (1)
LOT-0001
Anifrolumab-containing medicinal products
The lot covers ongoing deliveries of medicinal products containing anifrolumab according to the contracting authority's current needs over a four-year period. Lot-specific quantities, product specifications, delivery arrangements, and value are not provided in the structured data.
EUR 372k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
nejnižší celková nabídková cena v Kč bez DPH/4 roky.
Show original TED data
Original lot title
Léčivé přípravky s obsahem anifrolumabu
Original TED description
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem anifrolumabu po dobu 4 let dle aktuálních potřeb zadavatele.
Procurement Details
- Publication date
- 11 Oct 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 700339-2026
Documents (1)
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
67 / 100
Risk factors
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications